Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients

(Wiley-Blackwell) A recent study by Swedish researchers found that rheumatoid arthritis patients did not experience an elevated cancer risk in the first six years after starting anti-tumor necrosis factor therapy. Details of the study appear in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology published by Wiley-Blackwell.

source : www.eurekalert.org

Related News:

• Discovery Of Opposing Functions Of A Key Molecule In The Development Of Organisms Could Benefit Cancer Research
• SGO: Drug Combination Slows Recurrent Ovarian Cancer
• Researchers Develop Tool To Help Study Prostate Cancer
• Home Specimen Collection Boosts Cervical Cancer Screening
• Vitamin D slashes risk of bowel cancer by 40 percent
• Professor Discovers Link Between Low Oxygen Levels In Body And Cancer-Aiding Protein; Could Help Treatments For Retinoblastoma, Breast Cancer
• Reovirus may be a novel approach to prostate cancer treatment
• MHNCS: PET May Predict Cancer Aggression (CME/CE)
• The 27th Annual Miami Breast Cancer Conference
• Predictive Biosciences To Present Novel Combination Approach To Molecular Cancer Diagnostics At 2010 Genitourinary Cancers Symposium